-
Indian drug makers fit into Russia’s pharma strategy – Interview Shantanu Kumar Singh {Taj Pharma}
Russia’s $6 billion pharmaceutical programme Pharma2020, which aims to develop the country’s healthcare and pharmaceutical industry through supporting local drug manufacturers, would like to increase the share of domestically produced drugs to 50 percent by 2020 from 20 percent in 2007. For Indian drug manufacturers and exporters, the time has come to follow the strategy…
-
Trio of Indian pharmaceuticals millionaires launched 130 oncology generics [Taj Pharma] - chemotherapy drugs
Owners of Taj Pharmaceuticals have launched 130 innovative oncology to increase patient access their options for chemotherapy drugs Indian pharmaceuticals businessmen Abhishek Singh, Taj Pharmaceuticals Limited and Priyanka Singh could be in for a major windfall as one of Indian’s leading oncology care division manufacturing groups old unit is to be put up for sale…
-
Shantanu Kumar Singh – Executive Director – Taj Pharma Mumbai
The past two decades in pharmaceuticals and life sciences has been a rather rewarding for the industry with several patent expiry and first generations bio-similar in the industry. The conventional model of pharmaceuticals industry to market the products in the traditional model may not work anymore. The industry has seen several new laws for doctors…